Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evoke Pharma Inc EVOK

Healthcare
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The Company operates through the development and commercialization of pharmaceutical products. It is developing its product, Gimoti (metoclopramide) nasal spray, the first and only nasally administered... see more

Recent & Breaking News (NDAQ:EVOK)

Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference

GlobeNewswire October 4, 2017

Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study

GlobeNewswire September 12, 2017

Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire September 5, 2017

Evoke Pharma Reports Second Quarter 2017 Results and Highlights

GlobeNewswire August 14, 2017

Investor Network: Evoke Pharma, Inc. to Host Earnings Call

Accesswire August 14, 2017

Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti™

GlobeNewswire August 14, 2017

Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results

GlobeNewswire August 7, 2017

Generic Drugs Stocks on Investors' Radar -- Catalyst Pharma, Lannett, Evoke Pharma, and Galectin Therapeutics

PR Newswire June 7, 2017

Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti

GlobeNewswire May 31, 2017

Evoke Pharma Reports First Quarter 2017 Results

GlobeNewswire May 15, 2017

Investor Network: Evoke Pharma, Inc. to Host Earnings Call

Accesswire May 15, 2017

Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017

GlobeNewswire May 10, 2017

Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results

GlobeNewswire May 1, 2017

How These Generic Drugs Stocks are Faring? -- Evoke Pharma, Neurocrine Biosciences, Lannett, and Catalent

PR Newswire April 24, 2017

Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma’s Proposed Comparative Exposure PK Trial for Gimoti NDA

GlobeNewswire April 4, 2017

Generic Drugs Stocks on Investors' Radar -- Mylan, Allergan, Horizon Pharma, and Evoke Pharma

PR Newswire March 23, 2017

Evoke Pharma’s Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017

GlobeNewswire March 21, 2017

Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results

GlobeNewswire March 15, 2017

Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Full-Year 2016 Financial Results

GlobeNewswire March 7, 2017

Evoke Pharma Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares

GlobeNewswire March 6, 2017